SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
Veracyte,
Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson,
chairman and chief executive officer, will present at the Cantor
Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017
at 2:15 p.m. Eastern Time in New York, NY.
The live webcast from the Cantor Fitzgerald conference and subsequent
replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com.
The replay of the webcast will be available shortly after conclusion of
the presentation and archived on the company's website for 90 days
following the presentation.
About Veracyte
Veracyte (NASDAQ: VCYT) is a leading genomic diagnostics company that is
fundamentally improving patient care by resolving diagnostic uncertainty
with evidence that is trustworthy and actionable. The company's products
uniquely combine genomic technology, clinical science and machine
learning to provide answers that give physicians and patients a clear
path forward without risky, costly surgery that is often unnecessary.
Since its founding in 2008, Veracyte has commercialized three genomic
tests, which are transforming the diagnosis of thyroid cancer, lung
cancer and idiopathic pulmonary fibrosis and collectively target a $2
billion market opportunity. Veracyte is based in South San Francisco,
California. For more information, please visit www.veracyte.com
and follow the company on Twitter (@veracyte).
Veracyte and the Veracyte logo are trademarks of Veracyte, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170913005481/en/
Veracyte, Inc.
Media:
Tracy Morris, 650-380-4413
tracy.morris@veracyte.com
or
Investors:
Jackie
Cossmon, 650-243-6371
jackie@veracyte.com
Source: Veracyte, Inc.
News Provided by Acquire Media